TORAY INDUSTRIES, INC.

- Country
- 🇹🇼Taiwan
- Ownership
- Public
- Established
- 1926-04-16
- Employees
- 48.1K
- Market Cap
- -
- Website
- http://www.toray.co.jp
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
- Conditions
- Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaGastric Cancer
- Interventions
- First Posted Date
- 2023-09-15
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 146
- Registration Number
- NCT06038578
- Locations
- 🇯🇵
Shizuoka Cancer Center, Nagaizumi-cho, Shizuoka, Japan
🇰🇷Chonnam National University Hwasun Hospital, Hwasun-gun, Jeollanam-do, Korea, Republic of
🇰🇷Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of
A Study of TRK-950 in Patients With Advanced Solid Tumors
- First Posted Date
- 2022-06-21
- Last Posted Date
- 2025-07-01
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 13
- Registration Number
- NCT05423262
- Locations
- 🇯🇵
National Cancer Center Hospital, Chuo Ku, Tokyo, Japan
Pilot Clinical Study of NOA-001 for ARDS (Acute Respiratory Distress Syndrome)
- Conditions
- Acute Respiratory Distress Syndrome
- Interventions
- Device: NOA-001
- First Posted Date
- 2021-03-18
- Last Posted Date
- 2024-07-09
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 45
- Registration Number
- NCT04804943
- Locations
- 🇯🇵
Showa University Hospital, Tokyo, Japan
A Study to Investigate the Safety and Efficacy of TRK-750 for the Treatment of Patients With CIPN (Chopin Study)
- Conditions
- Chemotherapy-induced Peripheral Neuropathy
- Interventions
- Drug: TRK-750/PlaceboDrug: Placebo/TRK-750
- First Posted Date
- 2020-02-25
- Last Posted Date
- 2022-03-15
- Lead Sponsor
- Toray Industries, Inc
- Registration Number
- NCT04282590
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
- Conditions
- Solid TumorColorectal CancerGastric CancerRenal Cell CarcinomaMelanomaEpithelial Ovarian CancerPrimary Peritoneal CancerFallopian Tube CancerCholangiocarcinomaBladder Cancer
- Interventions
- First Posted Date
- 2019-03-13
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 138
- Registration Number
- NCT03872947
- Locations
- 🇺🇸
HonorHealth Research Institute, Scottsdale, Arizona, United States
🇺🇸AOA-HOPE, Tucson, Arizona, United States
🇺🇸USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
Safety, Tolerability, and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis
- First Posted Date
- 2018-11-01
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 34
- Registration Number
- NCT03727802
- Locations
- 🇺🇸
Pulmonary Associates, Phoenix, Arizona, United States
🇺🇸Cedars-Sinai Medical Center (CSMC) - Women's Guild Lung Institute, Los Angeles, California, United States
🇺🇸UC Davis Medical Center, Sacramento, California, United States
Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food-effect of TRK-750
- Conditions
- Healthy, Peripheral Neuropathic Pain
- Interventions
- Drug: Placebo
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2018-12-19
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 105
- Registration Number
- NCT03346330
- Locations
- 🇬🇧
London, London, United Kingdom
TRK-700 Drug-Drug Interaction Study With Digoxin and Midazolam
- First Posted Date
- 2017-02-03
- Last Posted Date
- 2017-10-25
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 48
- Registration Number
- NCT03043248
- Locations
- 🇯🇵
Tokyo, Tokyo, Japan
TRK-820 Study in Subjects on Hemodialysis With or Without Uremic Pruritus
- First Posted Date
- 2016-12-23
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 23
- Registration Number
- NCT03002233
- Locations
- 🇧🇬
Bulgaria, Bulgaria, Bulgaria
🇩🇪Germany, Germany, Germany
A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors
- Conditions
- Locally Advanced or Metastatic Solid CarcinomasColon CancerCholangiocarcinoma
- Interventions
- First Posted Date
- 2016-12-13
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 38
- Registration Number
- NCT02990481
- Locations
- 🇺🇸
Mayo Clinic, Phoenix, Arizona, United States
🇺🇸HonorHealth Research Institute, Scottsdale, Arizona, United States
🇫🇷Centre Léon Bérard, Lyon, France